Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically...

Related Keywords

Marcy Graham ,Aadi Bioscience ,Aadi Bio ,Dave Lennon ,Nasdaq ,Prnewswire Aadi Bioscience Inc ,International Conference On Molecular ,Pinternational Gynecologic Cancer Society ,Molecular Targets ,Cancer Therapeutics ,Chief Executive ,Global Meeting ,Call Information ,Fast Track ,Private Securities Litigation Reform Act ,